MLTX LAWSUIT NOTICE: MoonLake Immunotherapeutics Faces Securities Fraud Class Action Due to Drug Trial Results – Contact BFA Law if You Suffered Losses
NEW YORK CITY, NY / ACCESS Newswire / November 10, 2025 / Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against MoonLake Immunotherapeutics (NASDAQ:MLTX) and certain of the Company’s senior executives for potential violations of the federal securities laws. If you invested in MoonLake, you are encouraged […]